<Lung Cancer>
- Motohashi, S., Nagato, K., Kunii, N., Yamamoto, H., Yamasaki, K., Okita, K., Hanaoka, H., Shimizu, N., Suzuki, M., Yoshino, I., Taniguchi, M., Fujisawa, T., and Nakayama, T.: A phase I-II study of α-galactosylceramide-pulsed IL-2/GM-CSF-cultured peripheral blood mononuclear cells in patients with advanced and recurrent non-small cell lung cancer. J. Immunol. 182:2492-2501 (2009).
- Motohashi, S., and Nakayama, T.: Invariant natural killer T cell-based immunotherapy for cancer. Immunotherapy 1:73-82 (2009).
- Motohashi, S., and Nakayama, T.: Natural killer T cell-mediated immunotherapy for malignant diseases. Frontiers in Bioscience S1:108-116 (2009).
- Motohashi, S., and Nakayama, T.: Clinical applications of natural killer T cell-based immunotherapy for cancer. Cancer Sci. 99:638-645 (2008).
- Motohashi, S., Ishikawa, A., Ishikawa, E., Otsuji, M., Iizasa, T., Hanaoka, H., Shimizu, N., Horiguchi, S., Okamoto, Y., Fujii, S., Taniguchi, M., Fujisawa, T., and Nakayama, T.: A phase I study of in vitro expanded natural killer T cells in patients with advanced and recurrent non-small cell lung cancer. Clin. Can. Res. 12:6079-6086 (2006).
- Ishikawa, E., Motohashi, S., Ishikawa, A., Ito, T., Uchida, T., Kaneko, T., Tanaka, Y., Horiguchi, S., Okamoto, Y., Fujisawa, T., Tsuboi, K., Taniguchi, M., Matsumura, A., and Nakayama, T.: Dendritic cell maturation by CD11c- T cells and Vα24+ natural killer T-cell activation by α-Galactosylceramide. Int. J. Cancer 117:265-273 (2005).
- Ishikawa, A., Motohashi, S., Ishikawa, E., Fuchida, H., Higashino, K., Otsuji, M., Iizasa, T., Nakayama, T., Taniguchi, M., and Fujisawa, T.: A phase I study of α-galactosylceramide (KRN7000)-pulsed dendritic cells in patients with advanced and recurrent non-small cell lung cancer. Clin. Can. Res. 11:1910-1917 (2005).
- Taniguchi, M., Seino K., and Nakayama, T.: The NKT cell system: bridging innate and acquired immunity. Nat. Immunol. 4:1164-1165 (2003).